| Execution period | Phase 1 focusing on South India; project implementation initiated immediately |
|---|
BSE filing, NSE: KABRADG. Summary written from the filing by ALFA Finder's alert engine.
Kabra Drugs Ltd: key numbers
- Share price
- ₹16.39
- Market cap
- ₹38.86 Cr
- Revenue (annual)
- ₹92.74 Cr
- Net profit (annual)
- ₹4.96 Cr
- P/E (TTM)
- 5.1×Sector 48.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kabra Drugs Ltd
All →Kabra Drugs Board Meeting Date
Kabra Drugs (now Aanjaay Industries) intimated a board meeting on 6 November 2026 to consider unaudited results for the quarter ended 30 September 2026. The filing is advance notice only.
Kabra Drugs Other Announcement
The company has filed its quarterly shareholding pattern for the period ending September 30, 2026. The document discloses the distribution of shareholding among various categories of investors.
Kabra Drugs Annual General Meeting
Aanjaay Industries Limited conducted its 37th Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and director appointments.
Kabra Drugs Annual Report
Aanjaay Industries Ltd has submitted its Annual Report for FY 2025-2026 and issued notice for its 37th AGM scheduled for 30th September 2026.
Kabra Drugs Annual General Meeting
Aanjaay Industries Limited announced book closure dates from September 24th to September 30th, 2026, for its Annual General Meeting scheduled for September 30th, 2026.
Kabra Drugs Board Meeting Outcome
Aanjaay Industries Limited announced the notice for its 37th Annual General Meeting and approved board agenda items, including the appointment of directors and auditors.
Other capacity expansion announcements
All →Infosys Capacity Expansion
Infosys inaugurated a new 1.1 million sq ft Software Development Block at its Pocharam campus in Hyderabad. The block adds 10,000 seats, supporting over 13,000 additional employees under a hybrid model.
- new development block seats
- 10000 seats
Avenue Supermarts Capacity Expansion
Avenue Supermarts opened a new store at GHS Mall, Pune today, taking its total store count to 519. This is a routine operational expansion with no monetary value disclosed.
- new stores
- 1.0 stores
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Shekhawati Industries Capacity Expansion
Shekhawati Industries entered a development agreement for a residential and commercial project at Mudre Khurd, Karjat. The project covers about 2,00,000 sq. ft. with around 200 apartments, marking its entry into real estate.
- development area
- 200000 sq. ft.
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
PNGS Reva Diamond Jewellery Capacity Expansion
PNGS Reva Jewellery opened its 6th exclusive brand store at Bavdhan, Pune. Total stores now stand at 34 SIS and 6 EBOs.
- Exclusive Brand Stores (EBO) opened
- 1 stores